Showing 24,801 - 24,820 results of 42,098 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( a ((nn decrease) OR (point decrease)) ))', query time: 1.11s Refine Results
  1. 24801

    HE images of the adherent cells in the 2D and 3D scaffold systems. by Lucrezia Ferretti (18806152)

    Published 2024
    “…Cells within SHE (5x magnification) reach 60% confluence at 24h (p) and a 100% confluence at 72h (q). Instead, in SHR1 (5x magnification), SHR2 and SHR3 (10x magnification) the cells barely reached 50% confluence at 72h, then the cellularity decreased between 72h and 7 days (j-o). 2D culture (5x magnification) show a higher cellularity in each time point compared to scaffolds (a-c). …”
  2. 24802

    Elicitation of the hippocampal theta by the stimuli. by Keita Tokuda (5661373)

    Published 2014
    “…Shown are the averages across all the trials for each stimulus type in the session 10 of a rat (50 trials each). x axis, time (in s); y axis, frequency (in Hz). …”
  3. 24803

    Defective spermatogenesis and altered expression of CREB in CF mice testis. by Wen Ming Xu (221689)

    Published 2011
    “…Bar  = 20 µm (upper panel) or 50 µm (lower panel). (<b>E</b>) Statistic shows slight decrease in tubular diameter is observed in −/− testes. …”
  4. 24804

    Development of the cell fitness multiplexing assay. by Daniel F. Gilbert (193637)

    Published 2011
    “…Luminescence signals (black) reach a maximum ten minutes after addition of CTG (see step 7 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0028338#pone-0028338-g001" target="_blank">Fig. 1A</a>) followed by linear decrease. …”
  5. 24805

    DataSheet1_Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder.docx by Chaoli Chen (20359785)

    Published 2024
    “…Background<p>In the treatment of depression, medication plays a crucial role. However, insufficient patient adherence to medication often results in unsatisfactory treatment outcomes, increasing both the recurrence and rehospitalization rates of depression, and consequently imposing a greater economic burden on the healthcare system.…”
  6. 24806

    Characterization of phenotypically unique accessions. by Maria Stefania Przybylska (22756354)

    Published 2025
    “…The map was created with data from Natural Earth via the R package <i><i>rnaturalearth</i></i> [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003536#pbio.3003536.ref030" target="_blank">30</a>] (basemap shapefile: <a href="https://www.naturalearthdata.com/downloads/50m-cultural-vectors/" target="_blank">https://www.naturalearthdata.com/downloads/50m-cultural-vectors/</a>). …”
  7. 24807
  8. 24808
  9. 24809
  10. 24810
  11. 24811
  12. 24812
  13. 24813
  14. 24814
  15. 24815
  16. 24816
  17. 24817
  18. 24818

    Data_Sheet_1_SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway.doc by Xiao-Ning Li (2008540)

    Published 2020
    “…In this study, we show that SWL-1 reverses resistance to fluconazole in C. albicans when delivered in combination, with a sharp decrease in the IC<sub>50</sub> of fluconazole from >200 to 3.74 ± 0.25 μg/ml, and also reverses the fluconazole resistance of C. albicans in vitro, with IC<sub>50</sub> from >200 to 5.3 ± 0.3 μg/ml. …”
  19. 24819

    An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers by Moran Elishmereni (203218)

    Published 2011
    “…Simulations of the verified model surfaced important therapeutic insights: (1) Fractionating the standard daily regimen (50 µg/dose) into a twice daily schedule (25 µg/dose) is advantageous, yielding a significantly lower tumor mass (45% decrease); (2) A low-dose (12 µg/day) regimen exerts a response similar to that obtained under the 50 µg/day treatment, suggestive of an equally efficacious dose with potentially reduced toxicity. …”
  20. 24820